Co-Authors
This is a "connection" page, showing publications co-authored by Alberto Zangrillo and Patrizia Rovere-Querini.
Connection Strength
3.680
-
A novel evidence-based algorithm to predict thromboembolism in patients with COVID-19: preliminary data from a single-centre cohort. Minerva Med. 2021 Jun 11.
Score: 0.238
-
Epicardial adipose tissue characteristics, obesity and clinical outcomes in COVID-19: A post-hoc analysis of a prospective cohort study. Nutr Metab Cardiovasc Dis. 2021 06 30; 31(7):2156-2164.
Score: 0.236
-
Pulmonary Vascular Thrombosis in COVID-19 Pneumonia. J Cardiothorac Vasc Anesth. 2021 Dec; 35(12):3631-3641.
Score: 0.231
-
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors. Clin Microbiol Infect. 2021 Mar; 27(3):451-457.
Score: 0.227
-
Biobanking for COVID-19 research. Panminerva Med. 2020 Oct 19.
Score: 0.227
-
Residual clinical damage after COVID-19: A retrospective and prospective observational cohort study. PLoS One. 2020; 15(10):e0239570.
Score: 0.227
-
Characteristics, treatment, outcomes and cause of death of invasively ventilated patients with COVID-19 ARDS in Milan, Italy. Crit Care Resusc. 2020 Sep; 22(3):200-211.
Score: 0.225
-
Recent exposure to smoking and COVID-19. Crit Care Resusc. 2020 09; 22(3):253-256.
Score: 0.225
-
Recent exposure to smoking and COVID-19. Crit Care Resusc. 2020 Jul 10.
Score: 0.223
-
Early predictors of clinical outcomes of COVID-19 outbreak in Milan, Italy. Clin Immunol. 2020 08; 217:108509.
Score: 0.222
-
Characteristics, treatment, outcomes and cause of death of invasively ventilated patients with COVID-19 ARDS in Milan, Italy. Crit Care Resusc. 2020 Apr 23.
Score: 0.220
-
Microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome (MicroCLOTS): an atypical acute respiratory distress syndrome working hypothesis. Crit Care Resusc. 2020 04 15; 22(2):95-97.
Score: 0.219
-
Fast reshaping of intensive care unit facilities in a large metropolitan hospital in Milan, Italy: facing the COVID-19 pandemic emergency Crit Care Resusc. 2020 04 01; 22(2):91-94.
Score: 0.219
-
Testosterone in males with COVID-19: A 7-month cohort study. Andrology. 2022 01; 10(1):34-41.
Score: 0.060
-
A radiological predictor for pneumomediastinum/pneumothorax in COVID-19 ARDS patients. J Crit Care. 2021 12; 66:14-19.
Score: 0.060
-
Respiratory Impairment Predicts Response to IL-1 and IL-6 Blockade in COVID-19 Patients With Severe Pneumonia and Hyper-Inflammation. Front Immunol. 2021; 12:675678.
Score: 0.059
-
Severely low testosterone in males with COVID-19: A case-control study. Andrology. 2021 07; 9(4):1043-1052.
Score: 0.058
-
Interleukin-1 and interleukin-6 inhibition compared with standard management in patients with COVID-19 and hyperinflammation: a cohort study. Lancet Rheumatol. 2021 Apr; 3(4):e253-e261.
Score: 0.058
-
COVID-19 survival associates with the immunoglobulin response to the SARS-CoV-2 spike receptor binding domain. J Clin Invest. 2020 12 01; 130(12):6366-6378.
Score: 0.057
-
Initial chest radiographs and artificial intelligence (AI) predict clinical outcomes in COVID-19 patients: analysis of 697 Italian patients. Eur Radiol. 2021 Mar; 31(3):1770-1779.
Score: 0.056
-
Stranger Months: How SARS-CoV-2, Fear of Contagion, and Lockdown Measures Impacted Attendance and Clinical Activity During February and March 2020 at an Urban Emergency Department in Milan. Disaster Med Public Health Prep. 2021 10; 15(5):e33-e42.
Score: 0.056
-
Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation: an open-label cohort study. Ann Rheum Dis. 2020 10; 79(10):1277-1285.
Score: 0.056
-
GM-CSF blockade with mavrilimumab in severe COVID-19 pneumonia and systemic hyperinflammation: a single-centre, prospective cohort study. Lancet Rheumatol. 2020 Aug; 2(8):e465-e473.
Score: 0.055
-
Hypocalcemia is highly prevalent and predicts hospitalization in patients with COVID-19. Endocrine. 2020 06; 68(3):475-478.
Score: 0.055
-
Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study. Eur J Intern Med. 2020 06; 76:43-49.
Score: 0.055
-
Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study. Lancet Rheumatol. 2020 Jun; 2(6):e325-e331.
Score: 0.055